CU20070150A7 - ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE - Google Patents
ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASEInfo
- Publication number
- CU20070150A7 CU20070150A7 CU20070150A CU20070150A CU20070150A7 CU 20070150 A7 CU20070150 A7 CU 20070150A7 CU 20070150 A CU20070150 A CU 20070150A CU 20070150 A CU20070150 A CU 20070150A CU 20070150 A7 CU20070150 A7 CU 20070150A7
- Authority
- CU
- Cuba
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- modified release
- solid pharmaceutical
- oral route
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N rivaroxaban Chemical compound S1C(Cl)=CC=C1C(=O)NC[C@@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(COCC2)=O)C1 KGFYHTZWPPHNLQ-AWEZNQCLSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a formas de dosificación farmacéutica sólidas administrables por vía oral que contienen 5-cloro-N({(5S)-2oxo-3-[4-(3-oxo-4morfolinil)fenil]-1,3-oxazolidin-5-il}metil)-2-tiofenocarboxamida con liberación modificada, así como a procedimientos para su fabricación, a su uso como medicamentos, a su uso para la profilaxis, la profilaxis secundaria y/o el tratamiento de enfermedades, así como a su uso para la fabricación de un medicamento para la profilaxis, la profilaxis secundaria y/o el tratamiento de enfermedades.The present invention relates to solid, orally administrable pharmaceutical dosage forms containing 5-chloro-N ({(5S) -2oxo-3- [4- (3-oxo-4morpholinyl) phenyl] -1,3-oxazolidin -5-yl} methyl) -2-thiophenecarboxamide with modified release, as well as procedures for its manufacture, its use as medicines, its use for prophylaxis, secondary prophylaxis and / or treatment of diseases, as well as a its use for the manufacture of a medicament for prophylaxis, secondary prophylaxis and / or the treatment of diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070150A CU23673B7 (en) | 2007-06-25 | 2007-06-25 | ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070150A CU23673B7 (en) | 2007-06-25 | 2007-06-25 | ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20070150A7 true CU20070150A7 (en) | 2009-09-08 |
| CU23673B7 CU23673B7 (en) | 2011-05-27 |
Family
ID=44280827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20070150A CU23673B7 (en) | 2007-06-25 | 2007-06-25 | ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23673B7 (en) |
-
2007
- 2007-06-25 CU CU20070150A patent/CU23673B7/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CU23673B7 (en) | 2011-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR052843A1 (en) | PHARMACEUTICAL DOSAGE METHODS ADMINISTRABLE SOLIDS BY ROUTE WITH MODIFIED RELEASE | |
| ECSP088339A (en) | SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE | |
| ECSP066584A (en) | PROCEDURE FOR THE PRODUCTION OF A SOLID PHARMACEUTICAL COMPOSITION OF ORAL ADMINISTRATION | |
| CO6460769A2 (en) | NEW VIRAL REPLICATION INHIBITORS | |
| DOP2011000218A (en) | SULFONAMIDE DERIVATIVES | |
| UY33246A (en) | TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS | |
| UY33241A (en) | ? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?. | |
| CR11455A (en) | NEW CYCL HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | |
| UA112055C2 (en) | SALTS 4- [2 - [[5-METHYL-1- (2-NAPHTHALINYL) -1H-PYRAZOL-3-yl] OXY] ETHYL] MORPHOLINE | |
| CO2018005842A2 (en) | Pharmaceutical composition comprising a potent urat 1 inhibitor | |
| DOP2015000001A (en) | FORMS OF PHARMACEUTICAL ADMINISTRATION INCLUDING 5-CHLORINE-N - ({(5S) -2-OXO-4 MORFOLINIL) PHENYL] -1,3-OXAZOLIDIN-5-IL} METHYL) -2-THIOFENCARBOXAMIDE | |
| DK1987026T3 (en) | Aminoacyl prodrug derivatives and drugs for the treatment of thromboembolic diseases | |
| UY33529A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES? | |
| CU23673B7 (en) | ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE | |
| UY29305A1 (en) | ADMINISTRABLE SOLID PHARMACEUTICAL DOSAGE FORMS BY ORAL ROUTE WITH MODIFIED RELEASE | |
| DOP2005000265A (en) | PHARMACEUTICAL DOSAGE FORM ADMINISTRABLE SOLIDS BY ORAL ROUTE WITH MODIFIED RELEASE. | |
| EA200970125A1 (en) | APPLICATION OF FLUMAZENYL IN THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF DEPRESSIVE DISORDERS | |
| TH79956A (en) | A modified solid-release pharmaceutical dosage form that can be administered orally. | |
| UY28628A1 (en) | PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION | |
| EA200900173A1 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION | |
| NO20081982L (en) | Solid, orally administrable pharmaceutical dosage forms with rapid release of active compound | |
| GT201500189A (en) | AUTOTAXIN INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent | ||
| FD | Lapse (for not paying fees) |